lasmiditan
SMILES | CN1CCC(CC1)C(=O)c1cccc(n1)NC(=O)c1c(F)cc(cc1F)F |
InChIKey | XEDHVZKDSYZQBF-UHFFFAOYSA-N |
Chemical properties
Hydrogen bond acceptors | 4 |
Hydrogen bond donors | 1 |
Rotatable bonds | 4 |
Molecular weight (Da) | 377.1 |
Drug properties
Molecular type | Small molecule |
Endogenous/Surrogate | Surrogate |
Approved drug | Yes |
Bioactivities
Receptor | Activity | Source | |||||||
---|---|---|---|---|---|---|---|---|---|
GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
Receptor | Activity | Source | |||||||
---|---|---|---|---|---|---|---|---|---|
GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
β1 | ADRB1 | Human | Adrenoceptors | A | pEC50 | 8.19 | 8.19 | 8.19 | Drug Central |
β2 | ADRB2 | Human | Adrenoceptors | A | pEC50 | 8.03 | 8.03 | 8.03 | Drug Central |
β3 | ADRB3 | Human | Adrenoceptors | A | pEC50 | 8.21 | 8.21 | 8.21 | Drug Central |
β1 | ADRB1 | Human | Adrenoceptors | A | pEC50 | 6.4 | 6.4 | 6.4 | ChEMBL |
β2 | ADRB2 | Human | Adrenoceptors | A | pEC50 | 9.4 | 9.4 | 9.4 | ChEMBL |
β2 | ADRB2 | Human | Adrenoceptors | A | pEC50 | 9.4 | 9.4 | 9.4 | Guide to Pharmacology |
β3 | ADRB3 | Human | Adrenoceptors | A | pEC50 | 6.1 | 6.1 | 6.1 | ChEMBL |